CDC Expands Infectious Disease Surveillance Program Beyond COVID at 4 Major US Airports

“The Centers for Disease Control and Prevention (CDC) is expanding its infectious disease surveillance program at four major U.S. airports as part of a new pilot program to provide early detection of more than 30 known pathogens, including influenza A and B, respiratory syncytial virus (RSV), and SARS-CoV-2.

The pilot is part of the agency’s Traveler-based Genomic Surveillance (TGS) program, implemented by biotech companies Ginkgo Bioworks and XpresCheck and will last several months.

According to the Bill & Melinda Gates Foundation, Ginkgo Bioworks received a $2.3 million grant in October from the foundation, which also funds the CDC, the CDC Foundation, and numerous pharmaceutical companies that have developed or are developing vaccines for various pathogens tested as part of the pilot program.”

https://x.com/thechiefnerd/status/1721940289365917793

Full Story: https://bit.ly/3QrBW8p

@ChiefNerd